Biomaterials and 3D Bioprinting Strategies to Model Glioblastoma and the Blood-Brain Barrier

© 2020 Wiley-VCH GmbH.

Bibliographische Detailangaben
Veröffentlicht in:Advanced materials (Deerfield Beach, Fla.). - 1998. - 33(2021), 5 vom: 01. Feb., Seite e2004776
1. Verfasser: Tang, Min (VerfasserIn)
Weitere Verfasser: Rich, Jeremy N, Chen, Shaochen
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2021
Zugriff auf das übergeordnete Werk:Advanced materials (Deerfield Beach, Fla.)
Schlagworte:Journal Article Review 3D bioprinting 3D models biomaterials blood-brain barrier glioblastoma Biocompatible Materials
LEADER 01000caa a22002652 4500
001 NLM318912244
003 DE-627
005 20240923231856.0
007 cr uuu---uuuuu
008 231225s2021 xx |||||o 00| ||eng c
024 7 |a 10.1002/adma.202004776  |2 doi 
028 5 2 |a pubmed24n1545.xml 
035 |a (DE-627)NLM318912244 
035 |a (NLM)33326131 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Tang, Min  |e verfasserin  |4 aut 
245 1 0 |a Biomaterials and 3D Bioprinting Strategies to Model Glioblastoma and the Blood-Brain Barrier 
264 1 |c 2021 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 24.07.2024 
500 |a Date Revised 23.09.2024 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a © 2020 Wiley-VCH GmbH. 
520 |a Glioblastoma (GBM) is the most prevalent and lethal adult primary central nervous system cancer. An immunosuppresive and highly heterogeneous tumor microenvironment, restricted delivery of chemotherapy or immunotherapy through the blood-brain barrier (BBB), together with the brain's unique biochemical and anatomical features result in its universal recurrence and poor prognosis. As conventional models fail to predict therapeutic efficacy in GBM, in vitro 3D models of GBM and BBB leveraging patient- or healthy-individual-derived cells and biomaterials through 3D bioprinting technologies potentially mimic essential physiological and pathological features of GBM and BBB. 3D-bioprinted constructs enable investigation of cellular and cell-extracellular matrix interactions in a species-matched, high-throughput, and reproducible manner, serving as screening or drug delivery platforms. Here, an overview of current 3D-bioprinted GBM and BBB models is provided, elaborating on the microenvironmental compositions of GBM and BBB, relevant biomaterials to mimic the native tissues, and bioprinting strategies to implement the model fabrication. Collectively, 3D-bioprinted GBM and BBB models are promising systems and biomimetic alternatives to traditional models for more reliable mechanistic studies and preclinical drug screenings that may eventually accelerate the drug development process for GBM 
650 4 |a Journal Article 
650 4 |a Review 
650 4 |a 3D bioprinting 
650 4 |a 3D models 
650 4 |a biomaterials 
650 4 |a blood-brain barrier 
650 4 |a glioblastoma 
650 7 |a Biocompatible Materials  |2 NLM 
700 1 |a Rich, Jeremy N  |e verfasserin  |4 aut 
700 1 |a Chen, Shaochen  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Advanced materials (Deerfield Beach, Fla.)  |d 1998  |g 33(2021), 5 vom: 01. Feb., Seite e2004776  |w (DE-627)NLM098206397  |x 1521-4095  |7 nnns 
773 1 8 |g volume:33  |g year:2021  |g number:5  |g day:01  |g month:02  |g pages:e2004776 
856 4 0 |u http://dx.doi.org/10.1002/adma.202004776  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 33  |j 2021  |e 5  |b 01  |c 02  |h e2004776